Nemaura Medical EBITDA 2014-2023 | NMRD
Nemaura Medical ebitda from 2014 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Nemaura Medical Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-8 |
| 2022 | $-7 |
| 2021 | $-4 |
| 2020 | $-5 |
| 2019 | $-4 |
| 2018 | $-2 |
| 2017 | $-2 |
| 2016 | $-2 |
| 2015 | $-1 |
| 2014 | $-1 |
| Nemaura Medical Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-0 |
| 2023-09-30 | $-2 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-8 |
| 2022-12-31 | $-0 |
| 2022-09-30 | $2 |
| 2022-06-30 | $-1 |
| 2022-03-31 | $-7 |
| 2021-12-31 | $-0 |
| 2021-09-30 | $2 |
| 2021-06-30 | $-2 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $-1 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $-1 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-1 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-1 |
| 2018-09-30 | $-1 |
| 2018-06-30 | $-1 |
| 2018-03-31 | $-1 |
| 2017-12-31 | $-0 |
| 2017-09-30 | $-0 |
| 2017-06-30 | $-0 |
| 2017-03-31 | $-0 |
| 2016-12-31 | $-0 |
| 2016-09-30 | $-0 |
| 2016-06-30 | $-0 |
| 2016-03-31 | $-0 |
| 2015-12-31 | $-0 |
| 2015-09-30 | $-0 |
| 2015-06-30 | $-0 |
| 2015-03-31 | $-1 |
| 2014-12-31 | $-0 |
| 2014-09-30 | $-0 |
| 2014-06-30 | $-0 |
| 2014-03-31 | $-0 |
| 2013-12-31 | $-0 |
| 2013-09-30 | $-0 |
| 2013-06-30 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Nemaura Medical Inc. is a medical technology company. It engages in developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R), BEAT(TM) diabetes, and proBEAT(TM). SugarBEAT(R), a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor. Nemaura Medical Inc. is based in New York, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $210.334B | 25.69 |
| Intuitive Surgical (ISRG) | United States | $182.994B | 95.67 |
| Alcon (ALC) | Switzerland | $46.005B | 32.38 |
| Edwards Lifesciences (EW) | United States | $41.343B | 25.70 |
| IQVIA Holdings (IQV) | United States | $39.384B | 22.32 |
| IDEXX Laboratories (IDXX) | United States | $37.127B | 44.66 |
| DexCom (DXCM) | United States | $28.045B | 42.24 |
| STERIS (STE) | Ireland | $22.129B | 25.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.113B | 0.00 |
| Waters (WAT) | United States | $19.387B | 28.90 |
| Hologic (HOLX) | United States | $18.849B | 20.49 |
| Sysmex ADR (SSMXY) | Japan | $11.637B | 36.49 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.214B | 12.57 |
| Teleflex (TFX) | United States | $11.083B | 17.23 |
| Globus Medical (GMED) | United States | $10.165B | 28.44 |
| Penumbra (PEN) | United States | $8.207B | 79.43 |
| Glaukos (GKOS) | United States | $7.621B | 0.00 |
| Masimo (MASI) | United States | $7.601B | 40.71 |
| PROCEPT BioRobotics (PRCT) | United States | $4.855B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.358B | 24.70 |
| LivaNova (LIVN) | United Kingdom | $2.788B | 16.09 |
| Inari Medical (NARI) | United States | $2.757B | 0.00 |
| TransMedics (TMDX) | United States | $2.749B | 87.15 |
| Veracyte (VCYT) | United States | $2.688B | 166.67 |
| Nihon Kohden (NHNKY) | Japan | $2.611B | 16.25 |
| Elekta AB (EKTAY) | Sweden | $2.340B | 19.06 |
| Tandem Diabetes Care (TNDM) | United States | $2.118B | 0.00 |
| RxSight (RXST) | United States | $1.894B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.511B | 6.88 |
| Artivion (AORT) | United States | $1.116B | 102.42 |
| Pulse Biosciences (PLSE) | United States | $1.086B | 0.00 |
| OPKO Health (OPK) | United States | $1.060B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.854B | 14.52 |
| Alphatec Holdings (ATEC) | United States | $0.789B | 0.00 |
| IRadimed (IRMD) | United States | $0.671B | 36.26 |
| OrthoPediatrics (KIDS) | United States | $0.654B | 0.00 |
| AxoGen (AXGN) | United States | $0.633B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.624B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.622B | 15.71 |
| Pacific Biosciences Of California (PACB) | United States | $0.589B | 0.00 |
| SiBone (SIBN) | United States | $0.549B | 0.00 |
| Paragon 28 (FNA) | United States | $0.435B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.355B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.350B | 10.69 |
| CVRx (CVRX) | United States | $0.307B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.298B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.290B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.266B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.226B | 15.84 |
| Inogen (INGN) | United States | $0.220B | 0.00 |
| NeuroPace (NPCE) | United States | $0.202B | 0.00 |
| Nevro (NVRO) | United States | $0.201B | 0.00 |
| Accuray (ARAY) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.177B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.155B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.121B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.117B | 0.00 |
| 908 Devices (MASS) | United States | $0.113B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.111B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.111B | 16.46 |
| WORK Medical Technology Group (WOK) | China | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.075B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.067B | 0.00 |
| LENSAR (LNSR) | United States | $0.064B | 0.00 |
| InspireMD (NSPR) | Israel | $0.062B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Envoy Medical (COCH) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.048B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.045B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.037B | 0.00 |
| Neuronetics (STIM) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| Precision Optics (POCI) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.018B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |